{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:28:07Z","timestamp":1792704487718,"version":"4.5.0"},"reference-count":204,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18gk0110017"],"award-info":[{"award-number":["JP18gk0110017"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM114736"],"award-info":[{"award-number":["GM114736"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.bbmt.2019.02.012","type":"journal-article","created":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T12:22:17Z","timestamp":1550146937000},"page":"e226-e246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":208,"title":["Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future"],"prefix":"10.1016","volume":"25","author":[{"given":"Madeleine","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaukat","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Stapleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Wynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromasa","family":"Yabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9486-6336","authenticated-orcid":false,"given":"Yasutsugu","family":"Chinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap Jan","family":"Boelens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert W.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9330-0154","authenticated-orcid":false,"given":"Francyne","family":"Kubaski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dafne D.G.","family":"Horovitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneliese L.","family":"Barth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Serafini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ester","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji E.","family":"Orii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadao","family":"Orii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunji","family":"Tomatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2019.02.012_bib0001","series-title":"The Metabolic and Molecular Basis of Inherited Disease","first-page":"3421","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"2001"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0002","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/jcpt.12136","article-title":"Current and potential therapeutic strategies for mucopolysaccharidoses","volume":"39","author":"Noh","year":"2014","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0003","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ymgme.2014.12.001","article-title":"Therapies for the bone in mucopolysaccharidoses","volume":"114","author":"Tomatsu","year":"2015","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0004","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1136\/adc.72.3.263","article-title":"The mucopolysaccharidoses: a clinical review and guide to management","volume":"72","author":"Wraith","year":"1995","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0005","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-3476(98)70201-X","article-title":"Follow-up of nine patients with Hurler syndrome after bone marrow transplantation","volume":"133","author":"Guffon","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0006","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJM198412203112504","article-title":"Bone-marrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI): biochemical and clinical status 24 months after transplantation","volume":"311","author":"Krivit","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0007","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.seminhematol.2009.10.008","article-title":"Transplant outcomes in mucopolysaccharidoses","volume":"47","author":"Prasad","year":"2010","journal-title":"Semin Hematol"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0008","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/sj.bmt.1704105","article-title":"Outcome of 27 patients with Hurler's syndrome transplanted from either related or unrelated haematopoietic stem cell sources","volume":"31","author":"Souillet","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0009","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(81)91046-1","article-title":"Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation","volume":"2","author":"Hobbs","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0010","first-page":"62","article-title":"Early hematopoietic stem cell transplantation in a patient with severe mucopolysaccharidosis II: a 7-year follow-up","volume":"12","author":"Barth","year":"2017","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0011","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10545-005-0258-8","article-title":"Trends in haematopoietic cell transplantation for inborn errors of metabolism","volume":"29","author":"Boelens","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0012","first-page":"31","article-title":"Long-term therapeutic efficacy of allogenic bone marrow transplantation in a patient with mucopolysaccharidosis IVA","volume":"1","author":"Chinen","year":"2014","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0013","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.bbmt.2017.06.020","article-title":"Hematopoietic stem cell transplantation for patients with mucopolysaccharidosis II","volume":"23","author":"Kubaski","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0014","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.bbmt.2005.09.016","article-title":"Results of the Cord Blood Transplantation Study (COBLT): outcomes of unrelated donor umbilical cord blood transplantation in pediatric patients with lysosomal and peroxisomal storage diseases","volume":"12","author":"Martin","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0015","series-title":"Mucopolysaccharidoses Update","first-page":"235","article-title":"Mucopolysaccharidosis type IVA: clinical features, biochemistry, diagnosis, genetics and treatment","author":"Sawamoto","year":"2018"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0016","series-title":"Mucopolysaccharidoses Update","first-page":"165","article-title":"Mucopolysaccharidosis type II: clinical features, biochemistry, diagnosis, genetics, and treatment","author":"Tomatsu","year":"2018"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0017","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ymgme.2010.09.010","article-title":"Clinical outcomes following hematopoietic stem cell transplantation for the treatment of mucopolysaccharidosis VI","volume":"102","author":"Turbeville","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0018","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/j.bbmt.2016.08.015","article-title":"Allogeneic hematopoietic stem cell transplantation in thirty-four pediatric cases of mucopolysaccharidosis: a ten-year report from the China Childrens Transplant Group","volume":"22","author":"Wang","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0019","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ymgme.2015.09.011","article-title":"Hematopoietic stem cell transplantation for Morquio A syndrome","volume":"117","author":"Yabe","year":"2016","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0020","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.bmt.1701141","article-title":"Treatment of MPS VII (Sly disease) by allogeneic BMT in a female with homozygous A619V mutation","volume":"21","author":"Yamada","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0021","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbmt.2008.01.009","article-title":"The clinical outcome of Hurler syndrome after stem cell transplantation","volume":"14","author":"Aldenhoven","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0022","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1073\/pnas.64.1.360","article-title":"The defect in Hurler and Hunter syndromes, II: deficiency of specific factors involved in mucopolysaccharide degradation","volume":"64","author":"Fratantoni","year":"1969","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0023","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1634\/theoncologist.2014-0218","article-title":"Cost structure and clinical outcome of a stem cell transplantation program in a developing country: the experience in northeast Mexico","volume":"20","author":"Jaime-P\u00e9rez","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0024","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1365-2141.2009.07974.x","article-title":"Cord blood and bone marrow transplantation in inherited metabolic diseases: scientific basis, current status and future directions","volume":"148","author":"Prasad","year":"2010","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0025","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1182\/blood-2008-03-140830","article-title":"Unrelated donor umbilical cord blood transplantation for inherited metabolic disorders in 159 pediatric patients from a single center: influence of cellular composition of the graft on transplantation outcomes","volume":"112","author":"Prasad","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0026","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/asheducation-2005.1.377","article-title":"Umbilical cord blood transplantation: a new alternative option","author":"Tse","year":"2005","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0027","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ymgme.2009.05.006","article-title":"Localized donor cells in brain of a Hunter disease patient after cord blood stem cell transplantation","volume":"98","author":"Araya","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0028","doi-asserted-by":"crossref","first-page":"3981","DOI":"10.1182\/blood-2012-09-455238","article-title":"Outcomes of transplantation using various hematopoietic cell sources in children with Hurler syndrome after myeloablative conditioning","volume":"121","author":"Boelens","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0029","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.pcl.2009.11.004","article-title":"Current international perspectives on hematopoietic stem cell transplantation for inherited metabolic disorders","volume":"57","author":"Boelens","year":"2010","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0030","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbmt.2009.01.020","article-title":"Risk factor analysis of outcomes after unrelated cord blood transplantation in patients with Hurler syndrome","volume":"15","author":"Boelens","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0031","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1055\/s-0036-1584602","article-title":"Neurodevelopmental outcome after hematopoietic cell transplantation in inborn errors of metabolism: current considerations and future perspectives","volume":"47","author":"Boelens","year":"2016","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0032","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood-2011-01-329235","article-title":"Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report","volume":"118","author":"Miller","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0033","series-title":"ESH-EBMT Handbook on Haemopoietic Stem Cell Transplantation","first-page":"558","article-title":"HSCT in inborn errors of metabolism and osteopetrosis","author":"Boelens","year":"2012"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0034","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/bjh.13059","article-title":"Transplantation in inborn errors of metabolism: current considerations and future perspectives","volume":"167","author":"Boelens","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0035","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/sj.bmt.1705718","article-title":"Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure","volume":"40","author":"Boelens","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0036","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1182\/blood.V91.7.2601","article-title":"Hurler syndrome, II: outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group","volume":"91","author":"Peters","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0037","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.bbmt.2015.02.011","article-title":"Hematopoietic cell transplantation for mucopolysaccharidosis patients is safe and effective: results after implementation of international guidelines","volume":"21","author":"Aldenhoven","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0038","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1182\/blood-2014-11-608075","article-title":"Long-term outcome of Hurler syndrome patients after hematopoietic cell transplantation: an international multicenter study","volume":"125","author":"Aldenhoven","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0039","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ymgme.2010.08.009","article-title":"High antibody titer in an adult with Pompe disease affects treatment with alglucosidase alfa","volume":"101","author":"de Vries","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0040","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ymgme.2009.08.003","article-title":"Cross-reactive immunologic material status affects treatment outcomes in Pompe disease infants","volume":"99","author":"Kishnani","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0041","doi-asserted-by":"crossref","first-page":"12937","DOI":"10.1073\/pnas.91.26.12937","article-title":"Enzyme replacement in a canine model of Hurler syndrome","volume":"91","author":"Shull","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0042","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1542\/peds.2006-2156","article-title":"Enzyme replacement therapy in patients who have mucopolysaccharidosis I and are younger than 5 years: results of a multinational study of recombinant human alpha-L-iduronidase (laronidase)","volume":"120","author":"Wraith","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0043","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3324\/haematol.2011.058644","article-title":"Hematopoietic stem cell transplantation improves the high incidence of neutralizing allo-antibodies observed in Hurler's syndrome after pharmacological enzyme replacement therapy","volume":"97","author":"Saif","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0044","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jpeds.2008.07.004","article-title":"Use of enzyme replacement therapy (Laronidase) before hematopoietic stem cell transplantation for mucopolysaccharidosis I: experience in 18 patients","volume":"154","author":"Wynn","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ymgme.2014.11.002","article-title":"Activities of daily living in patients with Hunter syndrome: impact of enzyme replacement therapy and hematopoietic stem cell transplantation","volume":"114","author":"Tanjuakio","year":"2015","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0046","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00281-004-0166-2","article-title":"Allogeneic stem cell transplantation for the treatment of lysosomal and peroxisomal metabolic diseases","volume":"26","author":"Krivit","year":"2004","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0047","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/sj.bmt.1705970","article-title":"Emerging trends in transplantation of inherited metabolic diseases","volume":"41","author":"Prasad","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"Suppl 1","key":"10.1016\/j.bbmt.2019.02.012_bib0048","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1038\/sj.bmt.1704839","article-title":"Hematopoietic cell transplantation activity in Europe for inherited metabolic diseases: open issues and future directions","volume":"35","author":"Rovelli","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0049","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ymgme.2012.09.004","article-title":"Long-term efficacy of hematopoietic stem cell transplantation on brain involvement in patients with mucopolysaccharidosis type II: a nationwide survey in Japan","volume":"107","author":"Tanaka","year":"2012","journal-title":"Mol Genet Metab"},{"issue":"suppl 5","key":"10.1016\/j.bbmt.2019.02.012_bib0050","doi-asserted-by":"crossref","first-page":"v49","DOI":"10.1093\/rheumatology\/ker396","article-title":"Therapy for the mucopolysaccharidoses","volume":"50","author":"Valayannopoulos","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0051","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jpeds.2008.11.005","article-title":"Improved metabolic correction in patients with lysosomal storage disease treated with hematopoietic stem cell transplant compared with enzyme replacement therapy","volume":"154","author":"Wynn","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0052","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00711387","article-title":"Bone marrow transplantation in Hunter syndrome","volume":"18","author":"Coppa","year":"1995","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0053","first-page":"184","article-title":"Impact of enzyme replacement therapy and hematopoietic stem cell therapy on growth in patients with Hunter syndrome","volume":"1","author":"Patel","year":"2014","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0054","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.bmt.1705934","article-title":"Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome","volume":"41","author":"Tolar","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0055","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.2147\/DDDT.S68562","article-title":"Impact of enzyme replacement therapy and hematopoietic stem cell transplantation in patients with Morquio A syndrome","volume":"9","author":"Tomatsu","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0056","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1023\/A:1005525931994","article-title":"Long-term follow-up following bone marrow transplantation for Hunter disease","volume":"22","author":"Vellodi","year":"1999","journal-title":"J Inherit Metab Dis"},{"issue":"Suppl","key":"10.1016\/j.bbmt.2019.02.012_bib0057","first-page":"S115","article-title":"Impact of enzyme replacement therapy and hematopoietic stem cell therapy on growth in patients with Hunter syndrome","volume":"114","author":"Tomatsu","year":"2015","journal-title":"Mol Genet Metab"},{"issue":"suppl 1","key":"10.1016\/j.bbmt.2019.02.012_bib0058","first-page":"141","article-title":"Morquio A syndrome: diagnosis and current and future therapies","volume":"12","author":"Tomatsu","year":"2014","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0059","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/sj.bmt.1705586","article-title":"Analysis of factors affecting development of carpal tunnel syndrome in patients with Hurler syndrome after hematopoietic cell transplantation","volume":"39","author":"Khanna","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0060","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0002-9149(03)00909-3","article-title":"Usefulness of bone marrow transplantation in the Hurler syndrome","volume":"92","author":"Braunlin","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0061","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1023\/A:1005447232027","article-title":"Bone marrow transplantation for Maroteaux-Lamy syndrome (MPS VI): long-term follow-up","volume":"22","author":"Herskhovitz","year":"1999","journal-title":"J Inherit Metab Dis"},{"issue":"suppl 5","key":"10.1016\/j.bbmt.2019.02.012_bib0062","doi-asserted-by":"crossref","first-page":"v4","DOI":"10.1093\/rheumatology\/ker394","article-title":"Overview of the mucopolysaccharidoses","volume":"50","author":"Muenzer","year":"2011","journal-title":"Rheumatology (Oxford)"},{"issue":"suppl 2","key":"10.1016\/j.bbmt.2019.02.012_bib0063","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1038\/bmt.2008.62","article-title":"The controversial and changing role of haematopoietic cell transplantation for lysosomal storage disorders: an update","volume":"41","author":"Rovelli","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0064","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/01241398-200401000-00019","article-title":"Musculoskeletal manifestations of Hurler syndrome: long-term follow-up after bone marrow transplantation","volume":"24","author":"Weisstein","year":"2004","journal-title":"J Pediatr Orthop"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0065","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/nbt1030","article-title":"Characterizing biological products and assessing comparability following manufacturing changes","volume":"22","author":"Chirino","year":"2004","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0066","first-page":"2868","article-title":"Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I","volume":"118","author":"Dickson","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0067","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1056\/NEJM200101183440304","article-title":"Enzyme-replacement therapy in mucopolysaccharidosis I","volume":"344","author":"Kakkis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0068","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2165\/00003088-200645100-00002","article-title":"Nanomedicine: clinical applications of polyethylene glycol conjugated proteins and drugs","volume":"45","author":"Parveen","year":"2006","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0069","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1006\/mgme.2000.3140","article-title":"Enzyme replacement therapy in feline mucopolysaccharidosis I","volume":"72","author":"Kakkis","year":"2001","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4274\/balkanmedj.2017.0055","article-title":"A review of myeloablative vs reduced-intensity\/non-myeloablative regimens in allogeneic hematopoietic stem cell transplantations","volume":"34","author":"Atilla","year":"2017","journal-title":"Balkan Med J"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0071","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.transci.2011.01.019","article-title":"Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced-intensity conditioning","volume":"44","author":"Servais","year":"2011","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0072","series-title":"Thomas' Hematopoietic Cell Transplantation","article-title":"Preparative regimens and modification of regimen-related toxicities","author":"Bensinger","year":"2003"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0073","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1200\/JCO.2010.32.5936","article-title":"High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: overview of six randomized trials","volume":"29","author":"Berry","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0074","first-page":"131","article-title":"High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells","volume":"18","author":"Brunvand","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0075","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/annonc\/mdi017","article-title":"Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience","volume":"16","author":"De Giorgi","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0076","first-page":"769","article-title":"High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancer","volume":"17","author":"Demirer","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0077","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/sj.bmt.1701902","article-title":"Autoimmune thrombocytopenia in a patient with small cell lung cancer developing after chemotherapy and resolving following autologous peripheral blood stem cell transplantation","volume":"24","author":"Demirer","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0078","first-page":"907","article-title":"Influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation","volume":"15","author":"Demirer","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0079","first-page":"29","article-title":"Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia","volume":"18","author":"Demirer","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0080","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1038\/sj.bmt.1704291","article-title":"Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients","volume":"32","author":"Kroger","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0081","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/sj.bmt.1704153","article-title":"Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990-1999","volume":"32","author":"Pedrazzoli","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0082","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/bmt.2017.5","article-title":"Changes in the incidence, patterns and outcomes of graft failure following hematopoietic stem cell transplantation for Hurler syndrome","volume":"52","author":"Lum","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0083","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.bbmt.2013.11.027","article-title":"Fludarabine and exposure-targeted busulfan compares favorably with busulfan\/cyclophosphamide-based regimens in pediatric hematopoietic cell transplantation: maintaining efficacy with less toxicity","volume":"20","author":"Bartelink","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0084","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10545-016-0006-2","article-title":"Mortality after hematopoietic stem cell transplantation for severe mucopolysaccharidosis type I: the 30-year University of Minnesota experience","volume":"40","author":"Rodgers","year":"2017","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0085","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1056\/NEJMoa032613","article-title":"Cord-blood transplants from unrelated donors in patients with Hurler's syndrome","volume":"350","author":"Staba","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0086","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/petr.12109","article-title":"Outcomes of haematopoietic stem cell transplantation for inherited metabolic disorders: a report from the Australian and New Zealand Children's Haematology Oncology Group and the Australasian Bone Marrow Transplant Recipient Registry","volume":"17","author":"Mitchell","year":"2013","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0087","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/adc.76.2.92","article-title":"Bone marrow transplantation for mucopolysaccharidosis type I: experience of two British centres","volume":"76","author":"Vellodi","year":"1997","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0088","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.ymthe.2017.03.025","article-title":"Hematopoietic stem cell gene therapy for storage disease: current and new indications","volume":"25","author":"Biffi","year":"2017","journal-title":"Mol Ther"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0089","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41409-018-0175-8","article-title":"Busulfan, fludarabine, and cyclophosphamide (BFC) conditioning allowed stable engraftment after haplo-identical allogeneic stem cell transplantation in children with adrenoleukodystrophy and mucopolysaccharidosis","volume":"53","author":"Chen","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0090","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/FTD.0b013e3182a04fc7","article-title":"Association between busulfan exposure and outcome in children receiving intravenous busulfan before hematopoietic stem cell transplantation","volume":"36","author":"Ansari","year":"2014","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0091","first-page":"1","article-title":"United States Life Tables, 2000","volume":"51","author":"Arias","year":"2002","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0092","unstructured":"Vital statistics of the United States, 1980, Life tables. Hyattsville, MD: US Department of Health and Human Services; 1984, p. 1-21."},{"key":"10.1016\/j.bbmt.2019.02.012_bib0093","unstructured":"Vital statistics of the United States, 1990, Life tables. Hyattsville, MD: US Department of Health and Human Services; 1994, p. 1-27."},{"key":"10.1016\/j.bbmt.2019.02.012_bib0094","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s10545-017-0034-6","article-title":"Long term survival and cardiopulmonary outcome in children with Hurler syndrome after haematopoietic stem cell transplantation","volume":"40","author":"Lum","year":"2017","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0095","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/bmt.2009.319","article-title":"Pre-transplant risk factors affecting outcome in Hurler syndrome","volume":"45","author":"Orchard","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0096","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1111\/j.1460-9592.2012.03904.x","article-title":"Anesthetic care and perioperative complications of children with Morquio syndrome","volume":"22","author":"Theroux","year":"2012","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0097","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.bbmt.2012.04.001","article-title":"Costs and cost-effectiveness of hematopoietic cell transplantation","volume":"18","author":"Preussler","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0098","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s00277-012-1530-2","article-title":"Real-world costs of autologous and allogeneic stem cell transplantations for haematological diseases: a multicentre study","volume":"91","author":"Blommestein","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0099","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/sj.bmt.1705109","article-title":"Do minitransplants have minicosts? A cost comparison between myeloablative and nonmyeloablative allogeneic stem cell transplant in patients with acute myeloid leukemia","volume":"36","author":"Cordonnier","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0100","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/bmt.2012.248","article-title":"Pilot study of patient and caregiver out-of-pocket costs of allogeneic hematopoietic cell transplantation","volume":"48","author":"Majhail","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0101","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.bbmt.2009.01.011","article-title":"Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications","volume":"15","author":"Majhail","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0102","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.transproceed.2016.10.007","article-title":"Cost analysis of transplantation in Japan, performed with the use of the national database","volume":"49","author":"Kitazawa","year":"2017","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0103","first-page":"1","article-title":"Hematopoietic stem cell transplantation in mucopolysaccharidosis type II: a literature review and critical analysis","volume":"6","author":"Barth","year":"2018","journal-title":"JIEMS"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0104","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.tp.0000226171.43943.d3","article-title":"Costs of allogeneic hematopoietic stem cell transplantation","volume":"82","author":"Svahn","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0105","first-page":"2565","article-title":"Cost analysis of hematopoietic stem cell transplantation in adult patients with acute myeloid leukemia at King Chulalongkorn Memorial Hospital","volume":"90","author":"Ngamkiatphaisan","year":"2007","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0106","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/bmt.2016.35","article-title":"Haematopoietic cell transplants in Latin America","volume":"51","author":"Gale","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0107","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00431-011-1606-3","article-title":"The role of enzyme replacement therapy in severe Hunter syndrome: an expert panel consensus","volume":"171","author":"Muenzer","year":"2012","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0108","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","article-title":"Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy","volume":"167","author":"Wraith","year":"2008","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0109","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ymgme.2009.08.006","article-title":"Japan Elaprase Treatment (JET) study: idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (mucopolysaccharidosis II, MPS II)","volume":"99","author":"Okuyama","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0110","author":"Li"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0111","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/sj.bmt.1705401","article-title":"Haematopoietic cell transplantation (HCT) in combination with enzyme replacement therapy (ERT) in patients with Hurler syndrome","volume":"38","author":"Cox-Brinkman","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0112","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ymgme.2016.01.011","article-title":"Enzyme replacement therapy prior to haematopoietic stem cell transplantation in mucopolysaccharidosis type I: 10-year combined experience of 2 centres","volume":"117","author":"Ghosh","year":"2016","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0113","unstructured":"Australian Government Department of Health. Life Saving Drugs Program, 2013. Guidelines for the treatment of mucopolysaccharidosis type I (MPS I). Available at: http:\/\/www.health.gov.au\/internet\/main\/publishing.nsf\/Content\/lsdp-criteria. Accessed 28 February 2019."},{"key":"10.1016\/j.bbmt.2019.02.012_bib0114","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1542\/peds.2007-3847","article-title":"Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I","volume":"123","author":"Clarke","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0115","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ymgme.2006.08.007","article-title":"A follow-up study of MPS I patients treated with laronidase enzyme replacement therapy for 6 years","volume":"90","author":"Sifuentes","year":"2007","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0116","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jpeds.2004.01.046","article-title":"Enzyme replacement therapy for mucopolysaccharidosis I: a randomized, double-blinded, placebo-controlled, multinational study of recombinant human alpha-L-iduronidase (laronidase)","volume":"144","author":"Wraith","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0117","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1750-1172-6-55","article-title":"Enzyme replacement therapy and\/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure","volume":"6","author":"de Ru","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0118","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/01.GIM.0000154299.22120.6A","article-title":"Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome","volume":"7","author":"Grewal","year":"2005","journal-title":"Genet Med"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0119","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s10545-005-0136-4","article-title":"Marrow stromal cells from patients affected by MPS I differentially support haematopoietic progenitor cell development","volume":"28","author":"Baxter","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0120","doi-asserted-by":"crossref","first-page":"E96","DOI":"10.1111\/petr.12231","article-title":"Hematopoietic stem cell transplantation effects on spinal cord compression in Hurler","volume":"18","author":"Ferrara","year":"2014","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0121","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1136\/ard.2008.095315","article-title":"Musculoskeletal manifestations of lysosomal storage disorders","volume":"68","author":"Aldenhoven","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0122","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1302\/0301-620X.76B6.7983131","article-title":"Bone-marrow transplantation in Hurler's syndrome. Effect on skeletal development","volume":"76","author":"Field","year":"1994","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0123","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1750-1172-8-155","article-title":"Treatment of hip dysplasia in patients with mucopolysaccharidosis type I after hematopoietic stem cell transplantation: results of an international consensus procedure","volume":"8","author":"Langereis","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0124","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1097\/01241398-199611000-00006","article-title":"Hip dysplasia in Hurler's syndrome: orthopaedic management after bone marrow transplantation","volume":"16","author":"Masterson","year":"1996","journal-title":"J Pediatr Orthop"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0125","first-page":"17","article-title":"Prevalence and development of orthopaedic symptoms in the Dutch Hurler patient population after haematopoietic stem cell transplantation","volume":"9","author":"Stoop","year":"2013","journal-title":"JIMD Rep"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0126","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/BPO.0b013e3181649e25","article-title":"Mobility in Hurler syndrome","volume":"28","author":"Taylor","year":"2008","journal-title":"J Pediatr Orthop"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0127","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ymgme.2010.07.015","article-title":"Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI): a single dose of galsulfase further reduces urine glycosaminoglycans after hematopoietic stem cell transplantation","volume":"101","author":"Whitley","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0128","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2741\/4490","article-title":"Mucopolysaccharidosis VI: pathophysiology, diagnosis and treatment","volume":"22","author":"Harmatz","year":"2017","journal-title":"Front Biosci"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0129","first-page":"103","article-title":"Combined enzyme replacement therapy and hematopoietic stem cell transplantation in mucopolysaccharidosis type VI","volume":"2","author":"Sillence","year":"2012","journal-title":"JIMD Rep"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0130","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/ajmg.a.35263","article-title":"Enzyme replacement therapy improves joint motion and outcome of the 12-min walk test in a mucopolysaccharidosis type VI patient previously treated with bone marrow transplantation","volume":"158A","author":"Sohn","year":"2012","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0131","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1750-1172-3-24","article-title":"The prevalence of and survival in mucopolysaccharidosis I: Hurler, Hurler-Scheie and Scheie syndromes in the UK","volume":"3","author":"Moore","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0132","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood.V87.11.4894.bloodjournal87114894","article-title":"Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome","volume":"87","author":"Peters","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0133","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/ana.24246","article-title":"Early treatment is associated with improved cognition in Hurler syndrome","volume":"76","author":"Poe","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0134","series-title":"International multicenter study to identify predictors of long term outcome of Hurler syndrome patients after successful hematopoietic stem cell transplantation, 12th International Symposium on MPS and Related Diseases","first-page":"S08.07","author":"Boelens","year":"2012"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0135","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1182\/blood-2014-06-581207","article-title":"Neonatal bone marrow transplantation prevents bone pathology in a mouse model of mucopolysaccharidosis type I","volume":"125","author":"Pievani","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0136","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1182\/blood-2014-11-606681","article-title":"Early HSCT corrects the skeleton in MPS","volume":"125","author":"Kurtzberg","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0137","first-page":"65","article-title":"Long-term follow-up of post-hematopoietic stem cell transplantation for Hurler syndrome: clinical, biochemical, and pathological improvements","volume":"2","author":"Yasuda","year":"2015","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0138","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/sj.bmt.1705569","article-title":"Biochemical monitoring after haemopoietic stem cell transplant for Hurler syndrome (MPSIH): implications for functional outcome after transplant in metabolic disease","volume":"39","author":"Church","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0139","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1055\/s-0038-1667349","article-title":"Anesthesia risk and the mucopolysaccharidoses: a challenging and changing landscape","volume":"8","author":"Walker","year":"2018","journal-title":"J Child Sci"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0140","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1460-9592.2012.03825.x","article-title":"A retrospective audit of anesthetic techniques and complications in children with mucopolysaccharidoses","volume":"22","author":"Frawley","year":"2012","journal-title":"Paediatr Anaesth"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0141","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1460-9592.2012.03897.x","article-title":"Mucopolysaccharidosis type I (Hurler syndrome) and anesthesia: the impact of bone marrow transplantation, enzyme replacement therapy, and fiberoptic intubation on airway management","volume":"22","author":"Kirkpatrick","year":"2012","journal-title":"Paediatr Anaesth"},{"issue":"Suppl 2","key":"10.1016\/j.bbmt.2019.02.012_bib0142","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13052-018-0565-y","article-title":"Gene therapy for mucopolysaccharidoses: in vivo and ex vivo approaches","volume":"44","author":"Fraldi","year":"2018","journal-title":"Ital J Pediatr"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0143","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s004390050641","article-title":"Incidence of the mucopolysaccharidoses in Northern Ireland","volume":"101","author":"Nelson","year":"1997","journal-title":"Hum Genet"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0144","first-page":"5","article-title":"Growth charts for patients with Hunter syndrome","volume":"1","author":"Patel","year":"2014","journal-title":"Mol Genet Metab Rep"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0145","first-page":"81","article-title":"Effectiveness of early hematopoietic stem cell transplantation in preventing neurocognitive decline in mucopolysaccharidosis type II: a case series","volume":"41","author":"Selvanathan","year":"2018","journal-title":"JIMD Rep"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0146","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1021\/bc400319d","article-title":"Blood-brain barrier molecular Trojan horse enables imaging of brain uptake of radioiodinated recombinant protein in the rhesus monkey","volume":"24","author":"Boado","year":"2013","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0147","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s10545-014-9686-7","article-title":"Long-term experience with enzyme replacement therapy (ERT) in MPS II patients with a severe phenotype: an international case series","volume":"37","author":"Lampe","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0148","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ymgme.2014.07.008","article-title":"Novel heparan sulfate assay by using automated high-throughput mass spectrometry: application to monitoring and screening for mucopolysaccharidoses","volume":"113","author":"Shimada","year":"2014","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0149","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jpeds.2008.11.041","article-title":"Bone marrow transplantation in children with Hunter syndrome: outcome after 7 to 17 years","volume":"154","author":"Guffon","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0022-3476(96)70202-0","article-title":"Bone marrow transplantation in Hunter syndrome","volume":"129","author":"McKinnis","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0151","unstructured":"Conitech, Clinical Protocol And Therapeutic Guidelines Mucopolissacaridose Type II. in: M.o. Health. (Ed.), 2018, pp. 1-40."},{"key":"10.1016\/j.bbmt.2019.02.012_bib0152","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/gim.2017.30","article-title":"Treatment of mucopolysaccharidosis type II (Hunter syndrome): results from a systematic evidence review","volume":"19","author":"Bradley","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0153","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/21678707.2017.1296761","article-title":"Presentation and treatments for mucopolysaccharidosis type II (MPS II; Hunter syndrome)","volume":"5","author":"Stapleton","year":"2017","journal-title":"Expert Opin Orphan Drugs"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0154","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jamaoto.2013.597","article-title":"Improvements in sensorineural hearing loss after cord blood transplant in patients with mucopolysaccharidosis","volume":"138","author":"Da Costa","year":"2012","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0155","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s10545-008-0838-5","article-title":"Sanfilippo syndrome: a mini-review","volume":"31","author":"Valstar","year":"2008","journal-title":"J Inherit Metab Dis"},{"issue":"Suppl 1","key":"10.1016\/j.bbmt.2019.02.012_bib0156","first-page":"S176","article-title":"Poor cognitive outcome of eleven children with Sanfilippo syndrome after bone marrow transplantation and successful engraftment","volume":"15","author":"Klein","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0157","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/BF01800232","article-title":"Bone marrow transplantation for Sanfilippo disease type B","volume":"15","author":"Vellodi","year":"1992","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0158","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1023\/A:1005526628598","article-title":"Bone marrow transplantation in mucopolysaccharidosis type IIIA: a comparison of an early treated patient with his untreated sibling","volume":"22","author":"Sivakumur","year":"1999","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0159","first-page":"63","article-title":"Early umbilical cord blood-derived stem cell transplantation does not prevent neurological deterioration in mucopolysaccharidosis type III","volume":"18","author":"Welling","year":"2015","journal-title":"JIMD Rep"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0160","series-title":"Impairment of body growth in mucopolysaccharidoses","author":"Tomatsu","year":"2012"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0161","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2174\/138920111795542615","article-title":"Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment","volume":"12","author":"Tomatsu","year":"2011","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0162","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10545-007-0529-7","article-title":"International Morquio A Registry: clinical manifestation and natural course of Morquio A disease","volume":"30","author":"Monta\u00f1o","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0163","first-page":"65","article-title":"Current and emerging treatments and surgical interventions for Morquio A syndrome: a review","volume":"2012","author":"Tomatsu","year":"2012","journal-title":"Res Rep Endocr Disord"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0164","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/mgme.2001.3271","article-title":"Urinary glycosaminoglycan excretion quantified by an automated semimicro method in specimens conveniently transported from around the globe","volume":"75","author":"Whitley","year":"2002","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0165","doi-asserted-by":"crossref","DOI":"10.1111\/petr.12981","article-title":"Non-sibling hematopoietic stem cell transplantation using myeloablative conditioning regimen in children with Maroteaux-Lamy syndrome: a brief report","volume":"21","author":"Behfar","year":"2017","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0166","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1542\/peds.2006-2184","article-title":"Management guidelines for mucopolysaccharidosis VI","volume":"120","author":"Giugliani","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0167","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1750-1172-5-5","article-title":"Mucopolysaccharidosis VI","volume":"5","author":"Valayannopoulos","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0168","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jpeds.2005.12.014","volume":"148","author":"Harmatz","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0169","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ymgme.2008.04.001","article-title":"Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase","volume":"94","author":"Harmatz","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0170","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1750-1172-8-134","article-title":"Haploidentical stem cell transplantation in two children with mucopolysaccharidosis VI: clinical and biochemical outcome","volume":"8","author":"Jester","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0171","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jpeds.2007.04.054","article-title":"Hematopoietic cell therapy for metabolic disease","volume":"151","author":"Orchard","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0172","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12519-008-0031-9","article-title":"Long-term follow-up of a girl with Maroteaux-Lamy syndrome after bone marrow transplantation","volume":"4","author":"Wang","year":"2008","journal-title":"World J Pediatr"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0173","series-title":"Yearbook of Cell and Tissue Transplantation 1996\u20141997","first-page":"3","article-title":"Bone marrow transplantation","author":"Armitage","year":"1996"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0174","doi-asserted-by":"crossref","first-page":"255","DOI":"10.7326\/0003-4819-118-4-199302150-00003","article-title":"Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients","volume":"118","author":"McDonald","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0175","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1590\/S1415-47572010005000093","article-title":"Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment","volume":"33","author":"Giugliani","year":"2010","journal-title":"Genet Mol Biol"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0176","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/471325","article-title":"Glycosaminoglycan storage disorders: a review","volume":"2012","author":"Coutinho","year":"2012","journal-title":"Biochem Res Int"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0177","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s10545-011-9410-9","article-title":"Design, baseline characteristics, and early findings of the MPS VI (mucopolysaccharidosis VI) Clinical Surveillance Program (CSP)","volume":"36","author":"Hendriksz","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0178","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.bmt.1702528","article-title":"Umbilical cord blood transplantation for Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI)","volume":"26","author":"Lee","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0179","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0378-1119(90)90019-N","article-title":"Molecular basis of mucopolysaccharidosis type VII: replacement of Ala619 in beta-glucuronidase with Val","volume":"89","author":"Tomatsu","year":"1990","journal-title":"Gene"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0180","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/jmedgenet-2015-103322","article-title":"Clinical course of Sly syndrome (mucopolysaccharidosis type VII)","volume":"53","author":"Monta\u00f1o","year":"2016","journal-title":"J Med Genet"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0181","first-page":"89","article-title":"Mucopolysaccharidosis type VII: characterization of mutations and molecular heterogeneity","volume":"48","author":"Tomatsu","year":"1991","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0182","first-page":"676","article-title":"Treatment of murine mucopolysaccharidosis type VII by syngeneic bone marrow transplantation in neonates","volume":"68","author":"Sands","year":"1993","journal-title":"Lab Invest"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0183","unstructured":"Abeona Therapeutics, Inc. Phase I\/II Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH. 2016. Clinicaltrials.gov identifier NCT02716246."},{"key":"10.1016\/j.bbmt.2019.02.012_bib0184","unstructured":"LYSOGENE. An open-label, single arm, monocentric, phase I\/II clinical study of intracerebral administration of adeno-associated viral vector serotype 10 carrying the human SGSH and SUMF1 cDNAs for the treatment of Sanfilippo type A syndrome. Intracerebral gene therapy for Sanfilippo type A syndrome. 2011. Clinicaltrials.gov identifier NCT01474343."},{"key":"10.1016\/j.bbmt.2019.02.012_bib0185","unstructured":"LYSOGENE. Long-term follow-up of patients with Sanfilippo type A syndrome who have previously been treated in the P1-SAF-301 clinical study evaluating the tolerability and safety of the intracerebral administration of SAF-301. Long-term follow-up of Sanfilippo type A patients treated by intracerebral SAF-301 gene therapy. 2013. Clinicaltrials.gov identifier NCT02053064."},{"key":"10.1016\/j.bbmt.2019.02.012_bib0186","unstructured":"Fondazione Telethon. A phase I\/II open-label, dose-escalation safety study in subjects with mucopolysaccharidosis type VI (MPS VI) using adeno-associated viral vector 8 to deliver the human ARSB gene to liver. Gene therapy in patients with mucopolysaccharidosis disease. 2017. Clinicaltrials.gov identifier NCT03173521."},{"key":"10.1016\/j.bbmt.2019.02.012_bib0187","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ymgme.2017.12.434","article-title":"Gene therapy for mucopolysaccharidoses","volume":"123","author":"Sawamoto","year":"2018","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0188","unstructured":"Sangamo Therapeutics. Ascending dose study of genome editing by the Zinc Finger Nuclease (ZFN) therapeutic SB-318 in subjects with MPS I. A phase I, multicenter, open-label, single-dose, dose-ranging study to assess the safety and tolerability of SB-318, a rAAV2\/6-based gene transfer in subjects with mucopolysaccharidosis I (MPS I). 2016. ClinicalTrials.gov identifier NCT02702115."},{"key":"10.1016\/j.bbmt.2019.02.012_bib0189","unstructured":"Sangamo Therapeutics. Ascending dose study of genome editing by the Zinc Finger Nuclease (ZFN) therapeutic SB-913 in subjects with MPS II: a phase I, multicenter, open-label, single-dose, dose-ranging study to assess the safety and tolerability of SB-913, a rAAV2\/6-based gene transfer in subjects with mucopolysaccharidosis II (MPS II). 2017. ClinicalTrials.gov identifier NCT03041324."},{"key":"10.1016\/j.bbmt.2019.02.012_bib0190","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1182\/blood-2010-04-278234","article-title":"Gene therapy augments the efficacy of hematopoietic cell transplantation and fully corrects mucopolysaccharidosis type I phenotype in the mouse model","volume":"116","author":"Visigalli","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0191","unstructured":"IRCCS San Raffaele. Gene therapy with modified autologous hematopoietic stem cells for the treatment of patients with mucopolysaccharidosis type I, Hurler variant (TigetT10_MPSIH). 2018. ClinicalTrials.gov identifier NCT03488394."},{"key":"10.1016\/j.bbmt.2019.02.012_bib0192","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.stemcr.2017.02.010","article-title":"Efficient ex vivo engineering and expansion of highly purified human hematopoietic stem and progenitor cell populations for gene therapy","volume":"8","author":"Zonari","year":"2017","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0193","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1182\/blood-2004-03-0804","article-title":"Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors","volume":"104","author":"Diaconescu","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0194","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ymgme.2016.08.003","article-title":"Non-myeloablative preconditioning with ACK2 (anti-c-kit antibody) is efficient in bone marrow transplantation for murine models of mucopolysaccharidosis type II","volume":"119","author":"Yokoi","year":"2016","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0195","first-page":"366","article-title":"The cost of hematopoietic stem-cell transplantation in the United States","volume":"10","author":"Broder","year":"2017","journal-title":"Am Health Drug Benefits"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0196","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.soncn.2009.03.004","article-title":"History of hematopoietic stem cell transplantation","volume":"25","author":"Ezzone","year":"2009","journal-title":"Semin Oncol Nurs"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0197","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1056\/NEJM195709122571102","article-title":"Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy","volume":"257","author":"Thomas","year":"1957","journal-title":"New Engl J Med"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0198","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/sj.bmt.1702397","article-title":"Unrelated umbilical cord blood transplantation in infancy for mucopolysaccharidosis type IIB (Hunter syndrome) complicated by autoimmune hemolytic anemia","volume":"25","author":"Mullen","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0199","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3892\/ijmm.2012.1187","article-title":"New strategies for the treatment of lysosomal storage diseases (review)","volume":"31","author":"Parenti","year":"2013","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0200","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00004703-200608000-00002","article-title":"Long-term outcomes of adaptive functions for children with mucopolysaccharidosis I (Hurler syndrome) treated with hematopoietic stem cell transplantation","volume":"27","author":"Bjoraker","year":"2006","journal-title":"J Dev Behav Pediatr"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0201","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/BF00711520","article-title":"Long-term clinical progress in bone marrow transplanted mucopolysaccharidosis type I patients with a defined genotype","volume":"16","author":"Hopwood","year":"1993","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0202","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/S0140-6736(95)92597-X","article-title":"Allogeneic bone marrow transplantation for lysosomal storage diseases. The European Group for Bone Marrow Transplantation","volume":"345","author":"Hoogerbrugge","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0203","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/ajmg.1320460222","article-title":"Long-term outcome of Hurler syndrome following bone marrow transplantation","volume":"46","author":"Whitley","year":"1993","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.bbmt.2019.02.012_bib0204","first-page":"299","article-title":"The use of partially HLA-mismatched donors for allogeneic transplantation in patients with mucopolysaccharidosis-I","volume":"2","author":"Fleming","year":"1998","journal-title":"Pediatr Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119301375?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879119301375?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:06:32Z","timestamp":1761059192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879119301375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":204,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S1083879119301375"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.02.012","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hematopoietic Stem Cell Transplantation for Mucopolysaccharidoses: Past, Present, and Future","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2019.02.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}